ClinicalTrials.gg
RecruitingNCT05264675Updated Nov 14, 2024

Functional Outcome After EPL-rupture After Distal Radius Fracture

An observational study in Distal Radius Fracture, sponsored by Vastra Gotaland Region. Recruiting at 1 site in Sweden. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2024-11-14.

Sponsored by Vastra Gotaland Region · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Jan 2022; still recruiting 4 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
16 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 19 studies in Wrist Fractures with a site in Sweden — 4 open to participants now, 6 under way, none of them phase 3. Wrist Fractures · Sweden.

Started
2022
with 3 others
Observational
5 of 19
2 open now
Registered
13th of 19
by date

Among the 19 studies in Wrist Fractures with a site in Sweden, this one is one of 4 that started in 2022, is one of 5 observational ones, and was the 13th registered.

Wrist Fractures

330 studies on the registry are indexed under Wrist Fractures; 72 are open to participants now.

Browse Wrist Fractures studies →

Open to participants now

4 of the 19 studies in Wrist Fractures with a site in Sweden are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 43 Wrist Fractures studies recruiting now, 20 (47%) set no upper age limit and 15 (35%) stop at 75 or younger; 7 take children under 18; 6 take healthy volunteers.

This study: 16 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Wrist Fractures with a site in Sweden, or all of them as a file.
02

Study summary

Rupture of the extensor pollicis longus, (EPL) is a common complication after distal radius fractures. A rupture prevents the thumb extension, which in turn has a negative impact on hand function. An EPL-rupture can either be surgically treated by primary suture, which means that the ends of the tendon are sutured. This is however not recommended if the tendon is weakened. In such cases the rupture can be treated by a transfer of, most often, extensor indicis proprius (EIP) to the thumb.

Distal radius fractures are common and a rupture of the EPL-tendon is a known complication thar interferes with hand function and therefore more studies on this patient group are warranted.

The aim of this prospective study is to compare regaining of thumb function after surgery, with the non-injured side, after primary suture and EIP-transfer after EPL-rupture as a complication following distal radius fracture.

Read the detailed description

Rupture of the long extensor tendon of the thumb (extensor pollicis longus, EPL) is a common complication after distal radius fracture. The incidence has been shown to be about 1% after surgical treatment of the fracture and up to 5% after non-surgical treatment.

The reason why the tendon ruptures after minimally displaced fractures may be reduced blood flow to the tendon. After surgical treatment of a fracture, the cause of rupture may be irritation of the tendon caused by the osteosynthesis material. A rupture means that the thumb cannot be extended, which affects the function of the hand negatively.

EPL rupture can either be operated with primary suture, which means that the ends of the tendon are found and sutured, however this is not recommended if the tendon is weakened, for example due to poor vascularisation. In such a case, the EPL rupture can be repaired by moving a tendon, (usually the extensor indicis proprius, EIP), to the thumb .

Previous studies focusing on function after EPL rupture have been small and have not differentiated EPL ruptures with different underlying causes and the regimen of post-operative care has not been uniform.

Since distal radius fracture is a very common injury and rupture of the EPL tendon is a known complication that affects hand function, it is important that more studies are done on this patient group. Function should be evaluated both with objective and patient-related outcome measures. Knowledge of function after surgery is important for patients, surgeons and rehabilitation staff.

Purpose

The purpose of the present prospective study is to compare recovery of thumb function relative to the non-injured side after primary suture and EIP transfer respectively in rupture of the EPL after distal radius fracture.

Questions

How do patients rate their function after primary suture or EIP transfer?

How much recovery of thumb function occurs relative to the non-injured hand?

Do the groups differ in these respects?

Intervention

After primary suture/tendon transfer and cast immobilization (4 weeks after primary suture and 2 weeks after tendon transfer, respectively), patients will begin exercise according to a specific exercise program for thumb mobility. Between training sessions, an individually adapted, static splint is used with the thumb in extension (2 weeks after primary suture and 4 weeks after tendon transfer, respectively).

Six weeks postoperatively, free mobilization is allowed in light activities of daily living with progressively increased load and training according to the program continues.After twelve weeks, the patient has no restrictions regarding load.

Data collection will take place at 3 and 6 months postoperatively,

The grouping will be based on the treatment method chosen by the surgeon as this is related to the nature of the injury.

Power calculation

A power calculation was made based on the assumption that the group has a mean QuickDASH score of 25 points (SD 8) preoperatively and that the difference between the groups would be 6.8 points, which corresponds to "minimal clinically important difference". To reach a power of 0.80 with alpha 0.05, 22 patients per group are needed. To compensate for a presumed dropout, 30 patients per group are planned to be included.

The patients will be selected via the planning system for operations. The inclusion is expected to last for up to two years.

Data processing

Grip and pinch strength and mobility will be calculated as a percentage of the non-injured side and an average of the percentage will be calculated. Any statistical difference between operated and non-operated side and between the groups will be calculated with t-test.

Expected result / Clinical significance

The expected result is that the patients regain a large part of their function, which is of great importance for the individual patient, no difference between the groups is expected to emerge.

The study is expected to confirm that the treatment regimens used work well, which is important as Sahlgrenska University Hospital strives to use evidence-based treatment methods.

03

Conditions studied

  • Distal Radius Fracture

Browse trials for

Keywords

  • EPL-rupture
  • Distal radius fracture
  • Function
  • ADL
04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients with distal radius fractures who suffer from rupture of the EPL-tendon

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Distal Radius Fracture
  • EPL-rupture

Exclusion criteria

Exclusion Criteria:

  • comorbidity interfering with thumb function
  • inability to fill in forms
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Primary suture

    primary suture of EPL

    Procedure: primary suture

  • EIP- transfer

    transfer of the EIP to EPL

    Procedure: EIP-transfer

Interventions

  • Procedureprimary suture

    Primary suture of the EPL-tendon

  • ProcedureEIP-transfer

    transfer of the EIP-tendon to the EPL-tendon

06

What researchers measure

Primary outcomes

  1. range of motion

    extension, flexion, abduction, retroposition of thumb

    Time frame: 3 months postoperatively

  2. range of motion

    extension, flexion, abduction, retroposition of thumb

    Time frame: 6 months postoperatively

Secondary outcomes

  1. strength

    pinch, lateral pinch, grip strength

    Time frame: 3 months postoperatively

  2. strength

    pinch, lateral pinch, grip strength

    Time frame: 6 months postoperatively

Other outcomes

  1. Quick-DASH (Disabilities of the Arm, Shoulder and Hand)

    Patient rating of function. Minimum score 0 points, maximum score 100 points. Higher scores indicate a worse outcome.

    Time frame: 3 months postoperatively

  2. Quick-DASH (Disabilities of the Arm, Shoulder and Hand)

    Patient rating of function. Minimum score 0 points, maximum score 100 points. Higher scores indicate a worse outcome.

    Time frame: 6 months postoperatively

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2022 (actual). Primary completion is estimated for Apr 2026, 51 months after the start.

Of 20 observational studies under Wrist Fractures, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 63. This study's planned 51 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 18, 2022
First posted
Mar 3, 2022
StartActual
Jan 1, 2022
Primary completionEst.
Apr 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Nov 14, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05264675
Responsible party
Sponsor
First posted
Mar 3, 2022
Start date
Jan 1, 2022
Primary completion
Apr 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Nov 14, 2024

Study contacts

Ingrid Andreasson, Md Dr
Contact
ingrid.f.andreasson@vgregion.se
+46 31 343 10 36
Ingrid Andreasson, Md Dr
principal investigator · Sahlgrenska Universitetssjukhuset

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion